2013
EMT-related miRNAs as a potential markers for prediction and early detection of metastasis in renal cell carcinoma
MLČOCHOVÁ, Hana, Renata HÉŽOVÁ, Táňa MACHÁČKOVÁ, Martina LOJOVÁ, Alexandr POPRACH et. al.Základní údaje
Originální název
EMT-related miRNAs as a potential markers for prediction and early detection of metastasis in renal cell carcinoma
Autoři
MLČOCHOVÁ, Hana (203 Česká republika, domácí), Renata HÉŽOVÁ (203 Česká republika, domácí), Táňa MACHÁČKOVÁ (203 Česká republika, domácí), Martina LOJOVÁ (203 Česká republika, domácí), Alexandr POPRACH (203 Česká republika), Radek LAKOMÝ (203 Česká republika), Pavel FABIAN (203 Česká republika), Marek SVOBODA (203 Česká republika), Rostislav VYZULA (203 Česká republika) a Ondřej SLABÝ (203 Česká republika, garant, domácí)
Vydání
TEMTIA 2013, The 6th International EMT Meeting, Alicante, Spain, 2013
Další údaje
Jazyk
angličtina
Typ výsledku
Konferenční abstrakt
Obor
30200 3.2 Clinical medicine
Stát vydavatele
Španělsko
Utajení
není předmětem státního či obchodního tajemství
Kód RIV
RIV/00216224:14740/13:00065638
Organizační jednotka
Středoevropský technologický institut
Klíčová slova anglicky
EMT; renal cell carcinoma; miRNAs; predictive biomarkers; metastases
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 18. 11. 2013 11:50, Mgr. Petra Vychytilová, Ph.D.
Anotace
V originále
Renal cell carcinoma (RCC) belongs among the most common adult kidney neoplasm. Because of the lack of early warning signals, a high percentage of patients with metastatic RCC occur. Nowadays, epithelial-mesenchymal transition (EMT) as a crucial event of the tumor progression resulting in metastasis is intensively studied. EMT is a biological process in which polarized epithelial cells undergo multiple biochemical changes altering their phenotype from epithelial to mesenchymal. This phenotype change observed during the tumor metastasis development is also accompanied on a molecular level by miRNAs deregulation. In our study, we try to identify EMT-related miRNAs that can be used in clinical practice as a predictors of metastatic risk and early relapse of the RCC. Five EMT-related miRNAs were studied on 3 different groups of RCC patients. Using Kruskal-Wallis test, miR-192 (p=0,0003), miR-200b (p=0,0145) a miR-215 (p<0,0001) showed significantly different miRNAs expression level between studying groups of RCC patients. Our primary data suggest that EMT-related tissue miRNAs (miR-192, miR-200b, miR-215) could potentially serve as a markers of RCC for differenciation between patiens without/with progression and primary metastatic patiens. No signifiant differences between patiens with and without progression were observed, however miR-192 showed decreasing level of expression depending on higher metastatic potential of the tumor. Further studies are needed to confirm suitability of these miRNA markers for individualisation of RCC therapy and their potential use in the clinical practice.
Návaznosti
NT13547, projekt VaV |
|